Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studiesFausto Petrelli, Vanesa Gregorc|PLoS ONE|2018Cited by 52
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLucia Del Mastro, A Parisi, Mario Giuliano et al.|The Lancet Oncology|2022Cited by 50